VIVOS THERAPEUTICS INC

NASDAQ: VVOS (Vivos Therapeutics, Inc.)

Last update: 3 days ago, 7:08PM

3.11

-0.08 (-2.51%)

Previous Close 3.19
Open 3.15
Volume 125,529
Avg. Volume (3M) 198,486
Market Cap 18,316,406
Price / Sales 0.780
Price / Book 2.45
52 Weeks Range
1.91 (-38%) — 6.28 (101%)
Earnings Date 31 Mar 2025
Profit Margin -86.19%
Operating Margin (TTM) -68.52%
Diluted EPS (TTM) -4.99
Quarterly Revenue Growth (YOY) 16.90%
Total Debt/Equity (MRQ) 21.44%
Current Ratio (MRQ) 1.44
Operating Cash Flow (TTM) -12.50 M
Levered Free Cash Flow (TTM) -8.98 M
Return on Assets (TTM) -60.87%
Return on Equity (TTM) -325.98%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock Vivos Therapeutics, Inc. Mixed -

AIStockmoo Score

-1.5
Analyst Consensus NA
Insider Activity NA
Price Volatility -2.0
Technical Moving Averages 0.0
Technical Oscillators -2.5
Average -1.50

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
VVOS 18 M - - 2.45
QDEL 2 B - - 0.790
IART 2 B - - 1.16
AHCO 1 B - 16.38 0.820
OFIX 670 M - - 1.30
LAB 659 M - - 0.970

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Sector Healthcare
Industry Medical Devices
Investment Style Small Value
% Held by Insiders 8.00%
% Held by Institutions 13.70%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria